drugset / Trial / NCT01784107
A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
Phase 1 : To evaluate MTD(Maximal tolerated dose)and DLT(Dose limiting Toxicity) of Belotecan and Ifosfamide. Phase 2 : To analyse efficacy and toxicity of Belotecan and Ifosfamide.
Timeline
- Start
- 2011-07
- Primary completion
- 2018-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Belotecan | Small molecule | — | — |
| Subject | Ifosfamide | Small molecule | — | — |